multiple regression analysis showed new york heart association class i for exercise tolerance ( p = 0.0004 ) and flecainide treatment ( p = 0.01 ) to be the main factors increasing the arrhythmia-free episode .
C0016229
flecainide
C0003811
arrhythmia